NEWS
All News
FDA Briefs
Oncology Icons
Special Reports
Voices from the Field
CONFERENCES
Conference Coverage
Conference Listing
Data Dialogue with the Oncology Brothers
MEDIA
All Videos
Case-Based Peer Perspectives
Expert Perspective Virtual Tumor Board
Interviews
Investigator Perspectives
Medical World News
Pivotal Practice Views with the Oncology Brothers
Podcasts
Precision Medicine
Speaking Out
PUBLICATIONS
All Publications
Evolving Paradigms
Peers & Perspectives in Oncology
Targeted Therapies in Oncology
CASE-BASED ROUNDTABLE
PARTNERS
RESOURCES
CME/CE
Clinical Trials
Precision Medicine Perspectives
Press Releases
Sponsored Content
Treatment Resources
SUBSCRIBE
Choose Specialty
BRAIN CANCER
BREAST CANCER
BREAST CANCER
GENITOURINARY CANCERS
GENITOURINARY CANCERS
GENITOURINARY CANCERS
GENITOURINARY CANCERS
GENOMIC TESTING
GENOMIC TESTING
GI CANCERS
GI CANCERS
GI CANCERS
GI CANCERS
GI CANCERS
GYNECOLOGIC CANCERS
GYNECOLOGIC CANCERS
GYNECOLOGIC CANCERS
GYNECOLOGIC CANCERS
HEAD & NECK CANCERS
HEMATOLOGY
HEMATOLOGY
IMMUNOTHERAPY
IMMUNOTHERAPY
LEUKEMIAS
LEUKEMIAS
LEUKEMIAS
LEUKEMIAS
LUNG CANCER
LUNG CANCER
LUNG CANCER
LUNG CANCER
LUNG CANCER
LYMPHOMAS
LYMPHOMAS
LYMPHOMAS
LYMPHOMAS
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
SARCOMA
SKIN CANCERS
SKIN CANCERS
THYROID CANCERS
Spotlight -
Biomarker-Driven Lung Cancer
GIST
HER2 Breast Cancer
Chronic Lymphocytic Leukemia
Small Cell Lung Cancer
Renal Cell Carcinoma
Choose Specialty
BRAIN CANCER
BREAST CANCER
BREAST CANCER
GENITOURINARY CANCERS
GENITOURINARY CANCERS
GENITOURINARY CANCERS
GENITOURINARY CANCERS
GENOMIC TESTING
GENOMIC TESTING
GI CANCERS
GI CANCERS
GI CANCERS
GI CANCERS
GI CANCERS
GYNECOLOGIC CANCERS
GYNECOLOGIC CANCERS
GYNECOLOGIC CANCERS
GYNECOLOGIC CANCERS
HEAD & NECK CANCERS
HEMATOLOGY
HEMATOLOGY
IMMUNOTHERAPY
IMMUNOTHERAPY
LEUKEMIAS
LEUKEMIAS
LEUKEMIAS
LEUKEMIAS
LUNG CANCER
LUNG CANCER
LUNG CANCER
LUNG CANCER
LUNG CANCER
LYMPHOMAS
LYMPHOMAS
LYMPHOMAS
LYMPHOMAS
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
SARCOMA
SKIN CANCERS
SKIN CANCERS
THYROID CANCERS
Spotlight
NEWS
CONFERENCES
MEDIA
PUBLICATIONS
CASE-BASED ROUNDTABLE
PARTNERS
RESOURCES
SUBSCRIBE
Advertisement
Treatment Approaches for Myeloproliferative Neoplasms
: Episode 3
Review of COMFORT I and COMFORT II Trials
May 14, 2024
Opinion
Video
Expert panelists highlight the COMFORT I and COMFORT II studies.
EP: 1.
Treatment Approaches for Myeloproliferative Neoplasms
EP: 2.
Patient Case 1: Patient with Intermediate Risk Myelofibrosis
Now Viewing
EP: 3.
Review of COMFORT I and COMFORT II Trials
EP: 4.
Expert Takeaways from COMFORT I and II Trial Results
EP: 5.
Managing Treatment Strategy for Patient Who Previously Declined ASCT
EP: 6.
Key Clinical Trials Highlighting JAK Inhibitors in Myelofibrosis Treatment
EP: 7.
Reviewing Impact of Emerging JAK Inhibitor Data
EP: 8.
Treatment of Advanced Polycythemia Vera
EP: 9.
Long-Term Outcomes with Ruxolitinib in Polycythemia Vera
EP: 10.
PROUD-PV/CONTINUATION-PV Trials for Ropeginterferon Alfa-2b in Polycythemia Vera
EP: 11.
MAJIC-PV Trial: Ruxolitinib vs Best Available Therapy in Hydroxyurea-Resistant/Intolerant Polycythemia Vera
Recent Videos
Related Content
Related Content